UMN Pharma, Adimmune To Partner For Greater China Vaccines
This article was originally published in PharmAsia News
Executive Summary
Japan's UMN Pharma and Taiwan's Adimmune have formed a partnership to produce vaccines and conduct clinical trials in China and Taiwan.